| Description |
COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (Serum Institute of India) |
| BNF code |
1404000ATBLAAAM |
| Virtual Medicinal Product |
Generic COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials |
| Name |
COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials |
| Abbreviated name |
COVID-19 Vaccine Covishield 0.5ml inj multidose vials |
| Supplier |
Serum Institute of India |
| Current licensing authority |
None |
| EMA additional monitoring |
✗ |
| Parallel import |
✗ |
| Restrictions on availability |
Restricted Availability |
|
Actual Medicinal Product Packs
|
|
COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (Serum Institute of India) 10 dose |
|
COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (Serum Institute of India) 20 dose |
|
COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (Serum Institute of India) 2 dose |
|
COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (Serum Institute of India) 5 dose |